Neural Therapeutics is an ethnobotanical drug-discovery company specializing in psychedelic-based medical therapeutics.
Neural Therapeutics has raised $364K in total funding. The most recent round was Undisclosed. The last funding was announced in May 2024.
Neural Therapeutics is headquartered in Toronto, Canada.
Neural Therapeutics is an ethnobotanical drug-discovery company specializing in psychedelic-based medical therapeutics.
Neural Therapeutics is at the Undisclosed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neural Therapeutics — Funding & Investors." VCBacked, May 8, 2024, https://www.vcbacked.co/company/neural-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). Neural Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/neural-therapeutics
{{cite web |title=Neural Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/neural-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated